![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 29, 27152-27158, July 20, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Transducin Repeat-containing Protein by
JNK Signaling and Its Role in the Activation of NF-
B*
,
, and
**
From the
AMC Cancer Research Center, Lakewood,
Colorado 80214, § Ruttenberg Cancer Center, Mount Sinai
School of Medicine, New York, New York 10029, the ¶ Department of
Pathology, New York University, New York, New York 10016, and the
Department of Animal Biology, University of Pennsylvania,
Philadelphia, Pennsylvania 19104
Received for publication, January 2, 2001, and in revised form, May 9, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Activation of Jun N-kinase (JNK) and NF- The survival of living organisms depends on the promptness and
efficiency of their response to adverse changes in the environment. Eukaryotic cellular responses to stress involve immediate
post-transcriptional events within the maze of signal transduction
pathways (1). Activation of these pathways often leads to further
changes in gene expression and de novo synthesis of proteins
that exert a protective effect on the cell. Whereas tremendous progress
has been achieved in identification and characterization of key
regulatory elements of separate signaling pathways, the complexity of
coordination between simultaneously induced and transduced signals and
the role of these interactions in the outcome of signaling are largely underestimated and yet to be understood.
Activation of the stress-activated protein kinases (c-Jun N-terminal
kinases (JNK)1 and p38
kinases) and I The JNK and p38 pathways are preferentially activated by a diverse
array of cellular stresses including UV light, x-rays, hydrogen
peroxide (H2O2), heat and osmotic shock, and
withdrawal of growth factors. JNK are activated via upstream
phosphorylation by two distinct JNKKs, JNKK1/MKK4/SEK1 (4, 5) and
JNKK2/MKK7 (6, 7). The p38 subgroup is phosphorylated by MKK3, MKK4 (4), and MKK6 (8, 9). Eleven different kinases capable of
phosphorylating JNK and p38 kinases (including MEKK1-4, ASK1 and -2, TAK1, and others) have been identified as upstream activators of the
JNK/p38 pathway (reviewed in Ref. 2). The precise mechanisms of their
activation by stress are not yet comprehended in full. The outcome of
JNK/p38 signaling is stress-inducible
phosphorylation-dependent activation of their substrate
proteins, which include transcription factors (c-Jun, ATF2, Elk1,
etc.), apoptosis regulators (Bcl2, Bid, etc.), and other effectors.
Modulation of gene expression due to an increase in transactivation
potential and protein stability of proteins phosphorylated by JNK/p38
are among the mechanisms of JNK/p38-mediated effects. Recent evidence
for the role of JNK/p38 kinases in stabilization of the short lived
mRNAs of cytokines and growth factors (10-14) represents yet
another mode of the regulation by stress-activated protein kinases,
although the effector proteins, which mediate mRNA stabilization,
are largely unknown.
NF- Most of the stress stimuli, which induce NF- This phosphorylation serves as a recognition signal for seven WD40
repeats located at the carboxyl-terminal domains of Both phosphorylation of I In this study, we first demonstrate that cellular stress and induction
of stress-activated protein kinases increase the levels and activities
of Plasmids--
The constitutively active IKK Antibodies--
Monoclonal antibodies against FLAG tag (M2;
Sigma), MEKK1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and
SEK1 (New England Biolabs) were purchased. Polyclonal antibodies
against Northern Blot and Nuclear Run-on Analyses--
Twenty µg of
total RNA isolated from freshly harvested cells using TRI-reagent
(Molecular Research Center, Cincinnati, OH) was subjected to Northern
blotting analysis using random primer-labeled probes for human
Transfections, Immunoblotting, and Reporter Assays--
HeLa
epithelial cells and 293T human embryo kidney cells were maintained in
Dulbecco's modified Eagle's medium supplemented with 10% fetal
bovine serum and antibiotics (Life Technologies, Inc.). Mouse NIH-3T3
cells were grown in Dulbecco's modified Eagle's medium supplemented
with 10% calf serum and antibiotics (Life Technologies, Inc.).
Transfections were performed by the calcium precipitate method or
lipofection (LipofectAMINE Plus; Life Technologies, Inc.). The overall
amount of DNA in transfection mixtures was kept constant by the
addition of pCDNA3. Preparation of cell lysates and immunoblotting
were performed as described elsewhere (17). Briefly, for detection of
endogenous
Loading of cell lysates on gels was normalized for protein
concentration. The luciferase assay was performed using a kit
(Promega), and the data were normalized per transfection efficiency.
Solid Phase Protein Kinase Activity Assays--
JNK and IKK
activity in whole cell extracts (10 µg) was assessed in the solid
phase kinase assay with bacterially expressed glutathione
S-transferase-c-Jun (amino acids 5-89) or glutathione S-transferase-I Cellular Stress-mediated Activation of JNK Up-regulates
In the overexpression experiments,
JNK and p38 belong to a subfamily of stress-activated protein
kinases, and their activities are drastically up-regulated in response
to a variety of stress stimuli including oxidative and osmotic stress.
Thus, we next tested whether cellular stress affects the expression of
Irradiated 293T cells with UV led to even more robust (up to
8-10-fold) and prolonged (up to 8 h) elevation of the steady state levels of
In order to follow up the stress-inducible changes in the
Forced expression of mRNA Stabilization as a Mechanism of JNK- and Cellular
Stress-mediated Up-regulation of
Treatment of 293T cells (transfected with inactive JNKKAA)
with actinomycin D to inhibit transcription allowed us to observe degradation of endogenous
To further analyze the mechanisms underlying an increase in Activation of JNK Up-regulates NF- Activation of NF- In this study, we have demonstrated that cellular stress and activation
of JNK pathway results in accumulation of
B
transcription factor are the hallmarks of cellular response to stress.
Phosphorylation of NF-
B inhibitor (I
B) by respective
stress-inducible kinases (IKK) is a key event in NF-
B activation.
-TrCP F-box protein mediates ubiquitination of phosphorylated I
B
via recruitment of SCF
-TrCP-Roc1 E3 ubiquitin
ligase complex. Subsequent proteasome-dependent degradation
of I
B results in activation of the NF-
B pathway. We found that a
variety of cellular stress stimuli induce an increase in the steady
state levels of
-TrCP mRNA and protein levels in human cells.
Activation of stress-activated protein kinases JNK (and, to a lesser
extent, p38) by forced expression of constitutively active mutants of
JNKK2 and MKK6 (but not MEK1 or IKK
) also leads to accumulation of
-TrCP. Transcription of the
-TrCP gene is not required for JNK-mediated induction of
-TrCP. A synergistic effect of stimulation of IKK and JNK on the transcriptional activity of
NF-
B was observed. The mechanisms of
-TrCP induction via stress
and its role in NF-
B activation are discussed.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
B kinases (IKK) followed by AP1/ATF- and NF-
B-dependent transcription orchestrates the rapid
cellular response to a wide spectrum of exogenous and endogenous
stress-induced agents. These pleiotropic mediators of stress-induced
gene expression play a critical role in cell growth and
differentiation, apoptosis, and adaptive responses to changes in
cellular redox balance (reviewed in Refs. 2 and 3).
B is a dimeric transcription factor composed of members of the
Rel family. A large number of stress stimuli including UV irradiation,
ionizing radiation, viral infection, and reactive oxygen species can
activate NF-
B and its target genes. These target genes include those
involved in the immune response, inflammatory response, cell adhesion,
cell growth, and apoptosis. The activity of NF-
B is tightly
regulated at the level of its localization by a family of inhibitory
proteins, I
Bs, that sequester NF-
B in the cytoplasm of
unstimulated cells. Ubiquitin-dependent degradation of I
Bs
in response to stress results in the nuclear translocation and
transcriptional activity of NF-
B (reviewed in Ref. 15).
B, trigger a cascade of
events resulting in the activation of I
B kinases (IKK). IKK is a
large (>700-kDa) multicomponent enzyme complex containing two closely
related kinase subunits with identical structural domains, IKK
(IKK1) and IKK
(IKK2), and two accessory proteins, IKK
and IKAP
(reviewed in Ref. 3). Two members of the MAP kinase family,
NF-
B-inducing kinase (NIK) and MEKK1, have been shown to directly
interact with IKK and activate the kinase subunits in experiments based
on overexpression of the recombinant proteins. The requirements of NIK
and MEKK1 for activation of IKK by the relevant physiological stimuli
have not been proven, and the upstream kinases in this signaling
pathway remain to be identified (reviewed in Ref. 3). As an outcome of
their activation, IKK mediate phosphorylation of I
B on two critical
serine residues (e.g. serines 32 and 36 in I
B
, serines
19 and 23 in I
B
, and serines 18 and 22 in I
B
).
-TrCP (16) and HOS/Fbw1b proteins (17). Binding of
-TrCP/Fbw1a (or its
close relative HOS/Fbw1b) proteins to I
B mediates I
B ubiquitination (and subsequent 26S proteasome-dependent
degradation) through recruitment of the
SCF
-TrCP-Roc1 E3 ubiquitin ligase (reviewed in
Refs. 18-20). These proteins belong to a large family of ubiquitin
ligase receptors containing the 42-48-amino acid F-box motif, which is
required for binding to the protein Skp1 (21-23). Skp1 recruits
-TrCP/Fbw1a with Cdc53/cullin 1 and Roc1/Rbx1, thereby allowing the
SCF E3 ubiquitin ligase to tether ubiquitin-conjugating enzymes
(reviewed in Ref. 18).
B and
-TrCP binding are required for
I
B ubiquitination and degradation. Inhibition of
-TrCP/HOS function by expression of a dominant negative mutant abrogates the
degradation of I
B phosphorylated by the activated IKK (17, 24-30).
The endogenous levels of
-TrCP are low. These levels can be
up-regulated in some cells by the activation of the Wnt/
-catenin/Tcf signaling pathway, resulting in the activation of
NF-
B-dependent transcription (31). Interestingly,
although the functional Tcf was apparently required for up-regulation
of
-TrCP, we have failed to completely inhibit the effect of Wnt
(but not
-catenin) on
-TrCP levels by co-expression of the
dominant negative Tcf4. Moreover, it was consistently observed that
expression of Wnt was more efficient in the increase in
-TrCP levels
and NF-
B transcriptional activity as compared with expression of the
stable
-catenin mutant (31). Since it has been shown that Wnt exerts some of its effects in a
-catenin-independent manner via the JNK
pathway (32), we investigated whether the activation of JNK signaling
can actually regulate the abundance and activity of
-TrCP.
-TrCP via stabilization of
-TrCP mRNA. These data provide
a mechanism for the positive cooperation between activated JNK and IKK
in regulating the NF-
B transcriptional activity in response to
cellular stress.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
S177E,S181E
(IKKSE), 2x-
B-luciferase and glutathione
S-transferase-I
B expression vectors (33, 34),
constitutively active JNKK2 (JNKKCAA) and its inactive
counterpart (JNKKAA), and constitutively active MKK6
(MKK6D/D; Ref. 10) were a generous gift of M. Karin.
Constitutively active MEKK1 (
MEKK1) and dominant negative SEK1/MKK4
(SEKAL) were kindly provided by A. Minden and J. Woodgett.
The expression vector for constitutively active MEK1
(MEKEL) was a kind gift of S. Aaronson.
-TrCP expression
vector containing the 3'-untranslated region (3'-UTR) was a gift of R. Benarous (16).
-TrCP were raised by Zymed Laboratories
Inc. against synthetic peptide encompassing amino acid residues
NSSEREDCNNGEPPRKIIPEKNSLRQTY of
-TrCP and purified via a peptide
affinity column.
-TrCP. The membranes were stripped and rehybridized with a probe to
7S RNA to verify that equal amounts of RNA were loaded and transferred.
A nuclear run-on assay was performed as previously described (31).
-TrCP, 1 mg of protein lysates were immunoprecipitated
with
-TrCP antibody (1 µg), separated on 8% SDS-polyacrylamide
gel electrophoresis, transferred onto a nitrocellulose membrane, and
probed with
-TrCP antibody at a 1:500 dilution. Membranes were
developed with the ECL kit (Amersham Pharmacia Biotech) and exposed to film.
B (amino acids 1-54) in the presence of
[
-32P]ATP (50 cpm/fmol) as described elsewhere
(37).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-TrCP
mRNA and Protein Levels--
We have tested the effects of JNK on
-TrCP levels by forced expression of N terminus truncated MEKK1
(
MEKK1), which is known as a very potent upstream activator of JNK
pathway. As is evident from Fig.
1A, transfection of 293T human
embryo kidney cells with the
MEKK1 construct led to a robust
increase in the steady state levels of
-TrCP
mRNA, whereas the expression of the
-TrCP
close relative HOS (17) was hardly affected.

View larger version (27K):
[in a new window]
Fig. 1.
Activation of the JNK pathway elevates the
steady state levels of
-TrCP mRNA.
The representative results of three independent experiments are shown.
A, Northern blot analysis of RNA extracted from 293T cells
48 h after transfection with pCDNA3 or
MEKK1 plasmids (2 µg). B, Northern blot analysis of RNA extracted from 293T
cells 48 h after transfection with the indicated constructs
plasmids (5 µg each). The film is overexposed compared with
A in order to show a moderate effect of
MKK6D/D.
MEKK1 was reported to activate
JNK as well as IKK (38) and MEK (39). To investigate which of those
pathways contribute to induction of
-TrCP, we expressed the constructs encoding constitutively active IKK
(IKK
SE (15)), activator of JNK (JNKKCAA
(10)), activator of p38 (MKK6D/D (10)), and activator of
mitogen-activated protein kinase (MEK1S218E,S222L,
MEKEL (40)). We found that transfection of 293T cells with
JNKKCAA but not with IKK
SE or
MEKEL elevated the steady state levels of
-TrCP. A moderate increase in
-TrCP levels was observed after expression of
MKK6D/D (Fig. 1B). These data suggest that
activation of JNK (and, to some extent, the p38 kinase pathway) results
in the induction of
-TrCP.
-TrCP. An oxidative stress caused by treatment of 293T cells with H2O2 resulted in an
approximately 4-fold increase in the steady state levels of
-TrCP mRNA (Fig.
2A). This increase was
observed within 30 min and lasted up to 2 h. Similar extent and
kinetics of the up-regulation of
-TrCP
mRNA levels were achieved by incubation of cells in the presence of
tumor necrosis factor
(TNF
; 20 ng/ml).

View larger version (43K):
[in a new window]
Fig. 2.
Accumulation of
-TrCP mRNA in response to stress. 293T
cells were treated with H2O2 (100 µM; A) or UV (40 J/m2;
B) and harvested at the indicated time points after the
treatment. Total RNA was extracted and analyzed by Northern blot with
the
-TrCP and 7S probes. The representative results of three
independent experiments are shown.
-TrCP mRNA (Fig.
2B). Comparable results were obtained in the cells treated
with sorbitol (0.6 M) to induce a hyperosmotic
shock.2 Altogether, these data provide the evidence that
cellular stress and induction of stress-activated protein kinases
up-regulate the levels of
-TrCP mRNA. The
induction of two major
-TrCP mRNA species did not seem to be
coordinate; the accumulation of a longer transcript was more pronounced
in the stressed cells (Fig. 2, A and B). This
observation may reflect an alteration of
-TrCP mRNA processing
in response to stress, although the exact nature of this phenomenon
remains to be elucidated.
-TrCP
protein expression, we have developed a rabbit polyclonal antibody (see
"Materials and Methods") as a probe for endogenous
-TrCP. This
antibody readily recognized recombinant
-TrCP protein, whose
expression was driven by cytomegalovirus-based vector in 293T human
kidney cells or by baculovirus expression system in insect cells (Fig.
3A). The antibody specifically
interacted with
-TrCP but not with another F-box protein Fbx7 (Fig.
3B).

View larger version (21K):
[in a new window]
Fig. 3.
Characterization of the polyclonal antibody
against
-TrCP and the effects of JNK
activation and stress on the levels of endogenous
-TrCP. A, the lysates from 293T
cells transfected with pCDNA3 or
-TrCP expression vector as well
as the recombinant
-TrCP produced by baculovirus infection in insect
cells (
TrCPrec., right
lane) were separated on 8% SDS-polyacrylamide gel
electrophoresis, transferred onto nitrocellulose membrane, and analyzed
by immunoblotting with polyclonal antibody against
-TrCP.
B, the lysates from 293T cells transfected with the
FLAG-tagged Fbx7 or
-TrCP expression vector were separated on 8%
SDS-polyacrylamide gel electrophoresis, transferred onto nitrocellulose
membrane, and analyzed by immunoblotting with monoclonal antibody
against FLAG tag (upper panel) or polyclonal
antibody against
-TrCP (lower panel).
C, 293T cells were transfected with
MEKK1 (2 µg) and
SEKAL (8 µg) as indicated. Forty-eight hours later, the
cells were harvested, and the cell lysates were prepared and analyzed
for the levels of
-TrCP by immunoprecipitation followed by
immunoblotting (panel I) and expression of
MEKK1 (panel II) and SEKAL
(panel III) by direct immunoblotting as well as
for activities of IKK (panel IV) and JNK
(panel V) as described under "Materials and
Methods." A representative result of three independent experiments is
shown. D, 293T cells were treated with UV (40 J/m2), H2O2 (100 µM),
or TNF
(20 ng/ml; R&D Systems). One hour after treatment, the cells
were harvested, and the cell lysates were prepared and analyzed for the
levels of
-TrCP by immunoprecipitation and immunoblotting. A
representative result of two independent experiments is shown.
MEKK1 in 293T cells resulted in a robust
activation of JNK (Fig. 3C, panel V),
modest (if any) activation of IKK (Fig. 3C, panel
IV), and noticeable accumulation of endogenous
-TrCP
protein (Fig. 3C, panel I). All of
those effects of
MEKK1 were largely inhibited by co-expression of a
dominant negative JNKK/SEK construct (SEKAL (41)). The
control immunoblot analysis demonstrated that the effects of
SEKAL could not be explained by changes in the truncated
MEKK1 expression (Fig. 3C, panel II).
Treatment of cells with physiological JNK inducers UV,
H2O2, and TNF
also increased the steady
state levels of
-TrCP (Fig. 3D). These data indicate that
cellular stress and stress-mediated activation of JNK pathway leads to
an increase in the levels of
-TrCP protein.
-TrCP--
The Wnt pathway was
shown to elevate the
-TrCP levels in a manner that is not dependent
on
-TrCP gene transcription. To investigate
whether
-TrCP transcription is required for
induction of
-TrCP by the JNK pathway, we have carried out a run-on
assay with nuclei isolated from 293T cells transfected with
constitutively active
MEKK1 or pCDNA3 plasmids. Expression of
MEKK1 led to a robust increase in transcription of c-jun,
a well known downstream target of the JNK pathway (2, 3). We did not
detect any corresponding increase in the rate of
-TrCP transcription (Fig. 4A). These results suggest
that activation of
-TrCP gene promotor is not
required for up-regulation of
-TrCP by stress and JNK activation.

View larger version (36K):
[in a new window]
Fig. 4.
Induction of
-TrCP
by JNK does not require transcription of the
-TrCP gene. A, nuclear
run-on analysis of
-TrCP, 7S, and
c-jun transcription in the nuclei isolated from 293T cells
48 h after transfection with pCDNA3 or
MEKK1 vectors (10 µg each). The membranes were exposed for 3 h for
c-jun or overnight for
-TrCP and
7S. A representative of two independent experiments is shown.
B, Northern blot analysis of RNA isolated from 293T cells
transfected with 5 µg of either active JNKKCAA (3-h
autoradiography exposure) or inactive JNKKAA (48-h
exposure) and treated with actinomycin D (10 µg/ml) for the indicated
time points. A representative of two independent experiments is
shown.
-TrCP mRNA
within 2-4 h (Fig. 4B). In contrast to that, little
-TrCP mRNA degradation was seen in the
cells expressing constitutively active JNKKCAA (Fig.
4B). These data indicate that activation of JNK may lead to
stabilization of
-TrCP mRNA.
-TrCP
levels by cellular stress and JNK activation, we utilized the
expression of exogenous human cytomegalovirus-driven
-TrCP construct
containing an intact 3'-UTR in mouse NIH-3T3 cells. These cells did not
express any amounts of endogenous
-TrCP, which were detectable by
Northern blot analysis with either human (Fig.
5A) or mouse (data not shown)
probe. Treatment of NIH-3T3 cells, which express exogenous
-TrCP,
with H2O2 led to accumulation of
-TrCP
mRNA (Fig. 5A). Co-expression of constitutively active JNKKCAA (but not of inactive JNKKAA) also
increased the steady state levels of exogenous
-TrCP (Fig. 5B). Before finally concluding on a posttranscriptional
mechanism of
-TrCP induction, the effects of stress still needed to
be tested in the absence of the cytomegalovirus-driven transcription. To this end, we have inhibited transcription by treating the
transfected NIH 3T3 cells with actinomycin D and assessed the rate of
degradation of the exogenously expressed
-TrCP mRNA. This
mRNA was found rather unstable in the nonstressed cells (with the
estimated half-life of ~40 min). However, incubation of cells in the
presence of both actinomycin D and H2O2
prevented the degradation of
-TrCP-3'-UTR mRNA (Fig.
5C). Altogether, these findings strongly indicate that the
cellular stress-mediated increase in
-TrCP levels is realized through stabilization of
-TrCP mRNA.

View larger version (25K):
[in a new window]
Fig. 5.
Stabilization of
-TrCP mRNA by JNK activation and stress in
NIH-3T3 cells. The representative results of two independent
experiments are shown. A, Northern blot analysis of RNA
extracted from NIH-3T3 cells 48 h after transfection with
pCDNA3 or
-TrCP-3'-UTR (4 µg) and 1 h after treatment
with H2O2 (100 µM) as indicated.
B, Northern blot analysis of RNA extracted from NIH-3T3
cells 30 h after co-transfection with pCDNA3,
-TrCP-3'-UTR
(2 µg), and either active JNKKCAA or inactive
JNKKAA (2 µg each). C, NIH-3T3 cells were
transfected with
-TrCP-3'-UTR. Thirty hours later, the cells were
treated with actinomycin D (ActD; 10 µg/ml; lanes
3-10). At the time point 0 (15 min after the addition of
actinomycin D), H2O2 was added to the culture
medium as indicated (100 µM). Cells were harvested
at the indicated time points, and RNA was extracted and analyzed by
Northern blot.
B Transcriptional
Activities--
Elevation of the endogenous levels of
-TrCP may
result in an increase in the efficiency of I
B ubiquitination and
degradation, leading to the activation of NF-
B-dependent
transcription (31). We have indeed observed a cooperative effect of
constitutively active IKK and JNKK on acceleration of I
B degradation
measured by pulse chase in 293T cells.2 It has been
previously shown that
MEKK1 is capable of activating the NF-
B
driven reporters under overexpression conditions (38, 42). To examine
the possible effect of JNK-mediated accumulation of
-TrCP on NF-
B
activities, we chose the conditions under which JNK is activated by
expression of its immediately upstream and most specific activator
JNKK. In order to exclude any effects on IKK activities, we saturated
I
B phosphorylation by forced expression of constitutively active
IKKSE. Expression of this construct in 293T cells readily
elevated the activity of NF-
B-driven luciferase reporter.
Remarkably, co-transfection of JNKKCAA resulted in further
increase in NF-
B transcriptional activity in a
dose-dependent manner (Fig.
6). Similar results were obtained in HeLa
cells. We did not detect any effects of JNKKCAA on the
activity of IKKSE measured in an immunokinase assay with
recombinant bacterially expressed glutathione
S-transferase-I
B
as a substrate (data not shown).
These data suggest that JNK cooperates with IKK in induction of NF-
B
transcriptional activity and that JNK-mediated up-regulation of
-TrCP may serve as a mechanism of this cooperation.

View larger version (12K):
[in a new window]
Fig. 6.
Activation of JNK contributes to
NF-
B transcriptional activities. 293T
cells were transfected with 2x-
B-luciferase (400 ng) and
pRSV-
-gal (100 ng) together with the indicated (in ng) amount of
IKK
SE and JNKKCAA. Thirty hours later, the
luciferase activity was measured. Normalized arbitrary unit values of
two independent experiments (each in triplicate) are shown.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
B by stress and proinflammatory cytokines
requires that NF-
B be released from its cytoplasmic retention by
I
B. Ubiquitination and subsequent proteasome-dependent
degradation of I
B requires both phosphorylation of I
B by IKK and
recognition of phosphorylated I
B by
-TrCP/Fbw1a (27, 29, 30) or
its relative protein HOS/Fbw1b (17, 43). Several lines of evidence suggest that the cellular levels of Fbw1 proteins are critical for
I
B ubiquitination. First,
-TrCP basal expression is very low, and
-TrCP protein is hardly detected by a direct immunoblotting analysis
(Ref. 31 and this study). Second, the ubiquitination and degradation of
I
B is readily inhibited in living cells by squelching
-TrCP with
the phosphopeptides mimicking the phosphorylated I
B (44) or by
expression of F-box-deficient dominant negative
-TrCP mutants (24,
26, 27-30). Third, an increase in
-TrCP levels by Wnt signaling
promotes the transcriptional activation of NF-
B in response to an
increase in I
B phosphorylation by constitutively active IKK
(31).
-TrCP via stabilization of
-TrCP mRNA. The elevated levels of
-TrCP together with activation of IKK and subsequent I
B
phosphorylation contributes to a rapid I
B degradation and NF-
B
nuclear translocation in response to stress (Fig.
7). Therefore, the findings reported here
identify a mechanism underlying the cooperation between stress-induced activation of IKK and JNK pathways in the activation of
NF-
B-dependent transcription. Moreover, activation of
JNK by Dsh (32) may play a role in the induction of
-TrCP by the Wnt
pathway (31) in addition to
-catenin/Tcf-dependent
mechanisms (Fig. 7).

View larger version (17K):
[in a new window]
Fig. 7.
A model for cooperation between
stress-induced JNK and IKK in the activation of
NF-
B. Both phosphorylation of I
B by
IKK and recognition of phosphorylated I
B by the elevated levels of
-TrCP contribute to I
B degradation and NF-
B activation.
Activation of JNK by Dsh may also contribute to induction of
-TrCP
by the Wnt pathway.
Simultaneous activation of JNK and NF-
B by stress and
proinflammatory cytokines has been long reported and often attributed to the common components. Although several common signaling effectors (e.g. TRAF2 (45, 46), MEKK1 (38), and CIKS (47)) are known to signal to both JNK/p38 and IKK activation, little information is
available about the cooperation of those signaling pathways. Activation
of p38 kinase by salicylates was reported to inhibit I
B degradation
and NF-
B activation via suppression of IKK activities (48, 49). We
observed only a very modest accumulation of
-TrCP mRNA in
response to the p38 pathway activation (Fig. 1B). It has been recently found that DNA binding and transcriptional activation of
NF-
B induced by thioredoxin requires activation of JNK and can be
inhibited by overexpression of the dominant negative JNKK/JNK constructs (50). These data are in agreement with our findings that JNK
activation promotes NF-
B transcriptional activities. Coordinated
effects of IKK and JNK activation on I
B phosphorylation and the
recognition of phosphorylated I
B by
SCF
-TrCP-Roc1 E3 ubiquitin protein ligase provide
a good explanation for efficient activation of NF-
B by a broad
spectrum of cellular stress stimuli.
Our findings also suggest that some of the important cellular functions
of JNK may be attributed to its regulation of NF-
B transcriptional
output. For example, there is a positive correlation between JNK and
NF-
B activation in the regulation of apoptosis. In T lymphocytes,
activation of both signaling pathways results in induction of apoptosis
(51, 52). In some other cell types, both JNK and NF-
B are shown to
hold antiapoptotic function. For example, X protein of hepatitis B
virus inhibits Fas-mediated apoptosis and is associated with
up-regulation of both stress-activated protein kinase/JNK (53) and
NF-
B (54-56) pathways in hepatocytes. Expression of JNK2 is
required to suppress apoptosis in human tumor cells MCF-7 and HCT116
(57). Activation of NF-
B was also shown to prevent apoptosis in
these cells (58, 59). Both JNK and NF-
B prevent apoptosis induced by
c-Myc overexpression in fibroblasts (60, 61).
However, the suggested
-TrCP-dependent mechanism of
cooperation between JNK and NF-
B pathways may not necessarily exist in all types of cells. Some cells (e.g. NIH-3T3) do not
express detectable levels of endogenous
-TrCP (Fig. 5), and,
therefore, they are not capable of modulation of NF-
B activity by
JNK through induction of
-TrCP. Thus, one should not expect a
universal concordance in JNK and NF-
B cellular functions including
the regulation of apoptosis.
Cellular stress and JNK activation elevate the steady state levels of
-TrCP in a transcription-independent manner. The finding that JNK
up-regulates the levels of
-TrCP via stabilization of its mRNA
is not entirely surprising. Activation of the JNK pathway has been
implicated in the stabilization of many short-lived mRNAs including
interleukin-2 (10), interleukin-3 (12), vascular endothelial growth
factor (14), and others. The effectors of stress, which mediate such
stabilization are largely unknown. Stability of many short lived
mRNAs, which contain AU-rich elements, is often controlled by HuR,
the ubiquitously expressed member of the ELAV protein family (reviewed
in Ref. 13). Analysis of the
-TrCP mRNA sequence revealed three
AU-rich elements, two of which are located in the 3'-UTR. Translocation
of the nuclear HuR protein to the cytoplasm is suggested to constitute
one of the mechanisms of HuR-mediated stabilization of
p21CIP/WAF mRNA in response to stress (36). In addition
to three AU-rich elements,
-TrCP mRNA contains an
ACUACUGCCCAGTTTCC sequence in its 3'-UTR. This sequence closely
resembles a distal part of the JNK response element, which was found in
the 5'-UTR of interleukin-2 mRNA and mediated its
stabilization by
MEKK1 (11). YB-1 and nucleolin proteins were shown
to bind to the JNK response element (11). Future studies will determine
the role of these and other factors as well as AU-rich and JNK-response
elements in the regulation of
-TrCP mRNA stability.
Our data do not allow us to exclude the possibility that additional
mechanisms of stress-inducible accumulation of
-TrCP protein
(e.g. protein stabilization) may exist. The exact modes of
-TrCP induction by JNK are yet to be identified and future studies
are required to further delineate the mechanisms of
-TrCP-mediated cooperation between JNK and NF-
B activation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. M. Karin, R. Benarous, S. Aaronson, A. Minden, and J. Woodgett for the generous gifts of reagents. We thank Drs. V. Fried and H. Furneaux for critical suggestions and Dr. K. Spiegelman for help with the manuscript preparation.
| |
FOOTNOTES |
|---|
* This study was supported in part by National Institutes of Health Grants CA 92900 (to S. Y. F.) and CA 76262 (to T. J. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Dept. of Animal Biology, University of Pennsylvania, School of Veterinary Medicine, 3800 Spruce St., Rm. 161E VET, Philadelphia, PA 19104-6046. Tel.: 215-573-6949; Fax: 215-573-5188; E-mail: sfuks@vet.upenn.edu.
Published, JBC Papers in Press, May 24, 2001, DOI 10.1074/jbc.M100031200
2 V. Spiegelman and S. Fuchs, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
JNK, c-Jun
N-terminal kinase(s);
MEKK, mitogen-activated protein kinase kinase
kinase;
NF-
B, nuclear factor
B;
I
B, inhibitor of NF-
B;
IKK, I
B kinase(s);
MKK/MEK, mitogen-activated protein kinase kinase;
JNKK/SEK, JNK kinase;
-TrCP,
-transducin repeat-containing
protein;
HOS, homologue of Slimb;
SCF, Skp1-cullin 1-F-box protein
complex;
Fbw, F-box/WD40 domain protein;
TNF
, tumor necrosis factor
;
3'-UTR, 3'-untranslated region;
E3, ubiquitin-protein isopeptide
ligase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ronai, Z. (1999) Oncogene 18, 6084-6086 |
| 2. | Davis, R. J. (1999) Biochem. Soc. Symp. 64, 1-12 |
| 3. | Karin, M. (1999) J. Biol. Chem. 274, 27339-27342 |
| 4. | Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J., and Davis, R. J. (1995) Science 267, 682-685 |
| 5. | Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. (1994) Nature 372, 794-798 |
| 6. | Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y., and Nishida, E. (1997) EMBO J. 16, 7045-7053 |
| 7. | Tournier, C., Whitmarsh, A. J., Cavanagh, J., Barrett, T., and Davis, R. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7337-7342 |
| 8. | Moriguchi, T., Toyoshima, F., Gotoh, Y., Iwamatsu, A., Irie, K., Mori, E., Kuroyanagi, N., Hagiwara, M., Matsumoto, K., and Nishida, E. (1996) J. Biol. Chem. 271, 26981-26988 |
| 9. | Stein, B., Brady, H., Yang, M. X., Young, D. B., and Barbosa, M. S. (1996) J. Biol. Chem. 271, 11427-11433 |
| 10. | Chen, C. Y., Del Gatto-Konczak, F., Wu, Z., and Karin, M. (1998) Science 280, 1945-1949 |
| 11. | Chen, C. Y., Gherzi, R., Andersen, J. S., Gaietta, G., Jurchott, K., Royer, H. D., Mann, M., and Karin, M. (2000) Genes Dev. 14, 1236-1248 |
| 12. | Ming, X. F., Kaiser, M., and Moroni, C. (1998) EMBO J. 17, 6039-6048 |
| 13. | Mitchell, P., and Tollervey, D. (2000) Curr. Opin. Genet. Dev. 10, 193-198 |
| 14. | Pages, G., Berra, E., Milanini, J., Levy, A. P., and Pouyssegur, J. (2000) J. Biol. Chem. 275, 26484-26491 |
| 15. | Verma, I. M., and Stevenson, J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11758-11760 |
| 16. | Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R. (1998) Mol. Cell 1, 565-574 |
| 17. | Fuchs, S. Y., Chen, A., Xiong, Y., Pan, Z. Q., and Ronai, Z. (1999) Oncogene 18, 2039-2046 |
| 18. | Deshaies, R. J. (1999) Annu. Rev. Cell Dev. Biol. 15, 435-467 |
| 19. | Karin, M., and Ben-Neriah, Y. (2000) Annu. Rev. Immunol. 18, 621-663 |
| 20. | Laney, J. D., and Hochstrasser, M. (1999) Cell 97, 427-430 |
| 21. | Cenciarelli, C., Chiaur, D. S., Guardavaccaro, D., Parks, W., Vidal, M., and Pagano, M. (1999) Curr. Biol. 9, 1177-1179 |
| 22. | Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., and Elledge, S. J. (1996) Cell 86, 263-274 |
| 23. | Winston, J. T., Koepp, D. M., Zhu, C., Elledge, S. J., and Harper, J. W. (1999) Curr. Biol. 9, 1180-1182 |
| 24. | Hatakeyama, S., Kitagawa, M., Nakayama, K., Shirane, M., Matsumoto, M., Hattori, K., Higashi, H., Nakano, H., Okumura, K., Onoe, K., Good, R. A., and Nakayama, K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3859-3863 |
| 25. | Hattori, K., Hatakeyama, S., Shirane, M., Matsumoto, M., and Nakayama, K. (1999) J. Biol. Chem. 274, 29641-29647 |
| 26. | Kroll, M., Margottin, F., Kohl, A., Renard, P., Durand, H., Concordet, J. P., Bachelerie, F., Arenzana-Seisdedos, F., and Benarous, R. (1999) J. Biol. Chem. 274, 7941-7945 |
| 27. | Spencer, E., Jiang, J., and Chen, Z. J. (1999) Genes Dev. 13, 284-294 |
| 28. | Suzuki, H., Chiba, T., Kobayashi, M., Takeuchi, M., Suzuki, T., Ichiyama, A., Ikenoue, T., Omata, M., Furuichi, K., and Tanaka, K. (1999) Biochem. Biophys. Res. Commun. 256, 127-132 |
| 29. | Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., and Harper, J. W. (1999) Genes Dev. 13, 270-283 |
| 30. | Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., and Ben-Neriah, Y. (1998) Nature 396, 590-594 |
| 31. | Spiegelman, V. S., Slaga, T. J., Pagano, M., Minamoto, T., Ronai, Z., and Fuchs, S. Y. (2000) Mol. Cell 5, 877-882 |
| 32. | Boutros, M., Paricio, N., Strutt, D. I., and Mlodzik, M. (1998) Cell 94, 109-118 |
| 33. | Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., and Karin, M. (1997) Cell 91, 243-252 |
| 34. | DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997) Nature 388, 548-554 |
| 35. | Deleted in proof |
| 36. | Wang, W., Furneaux, H., Cheng, H., Caldwell, M. C., Hutter, D., Liu, Y., Holbrook, N., and Gorospe, M. (2000) Mol. Cell. Biol. 20, 760-769 |
| 37. | Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., Davis, R. J., and Ronai, Z. (1999) EMBO J. 18, 1321-1334 |
| 38. | Lee, F. S., Hagler, J., Chen, Z. J., and Maniatis, T. (1997) Cell 88, 213-222 |
| 39. | Xu, S., Robbins, D., Frost, J., Dang, A., Lange-Carter, C., and Cobb, M. H. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6808-6812 |
| 40. | Jaaro, H., Rubinfeld, H., Hanoch, T., and Seger, R. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3742-3747 |
| 41. | Tibbles, L. A., Ing, Y. L., Kiefer, F., Chan, J., Iscove, N., Woodgett, J. R., and Lassam, N. J. (1996) EMBO J. 15, 7026-7035 |
| 42. | Nemoto, S., DiDonato, J. A., and Lin, A. (1998) Mol. Cell. Biol. 18, 7336-7343 |
| 43. | Suzuki, H., Chiba, T., Suzuki, T., Fujita, T., Ikenoue, T., Omata, M., Furuichi, K., Shikama, H., and Tanaka, K. (2000) J. Biol. Chem. 275, 2877-2884 |
| 44. | Yaron, A., Gonen, H., Alkalay, I., Hatzubai, A., Jung, S., Beyth, S., Mercurio, F., Manning, A. M., Ciechanover, A., and Ben-Neriah, Y. (1997) EMBO J. 16, 6486-6494 |
| 45. | Liu, Z. G., Hsu, H., Goeddel, D. V., and Karin, M. (1996) Cell 87, 565-576 |
| 46. | Shi, C. S., Leonardi, A., Kyriakis, J., Siebenlist, U., and Kehrl, J. H. (1999) J. Immunol. 163, 3279-3285 |
| 47. | Leonardi, A., Chariot, A., Claudio, E., Cunningham, K., and Siebenlist, U. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 10494-10499 |
| 48. | Schwenger, P., Alpert, D., Skolnik, E. Y., and Vilcek, J. (1998) Mol. Cell. Biol. 18, 78-84 |
| 49. | Alpert, D., and Vilcek, J. (2000) J. Biol. Chem. 275, 10925-10929 |
| 50. | Das, K. C. (2001) J. Biol. Chem. 276, 4662-4670 |
| 51. | Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D. R. (1998) Mol. Cell 1, 543-551 |
| 52. | Kasibhatla, S., Tailor, P., Bonefoy-Berard, N., Mustelin, T., Altman, A., and Fotedar, A. (1999) Mol. Cell. Biol. 19, 2021-2031 |
| 53. | Diao, J., Khine, A. A., Sarangi, F., Hsu, E., Iorio, C., Tibbles, L. A., Woodgett, J. R., Penninger, J., and Richardson, C. D. (2000) J. Biol. Chem. 276, 8328-8340 |
| 54. | Chirillo, P., Falco, M., Puri, P. L., Artini, M., Balsano, C., Levrero, M., and Natoli, G. (1996) J. Virol. 70, 641-646 |
| 55. | Kekule, A. S., Lauer, U., Weiss, L., Hofschneider, P. H., and Koshy, R. (1992) Arch. Virol. Suppl. 4, 63-64 |
| 56. | Weil, R., Sirma, H., Giannini, C., Kremsdorf, D., Bessia, C., Dargemont, C., Brechot, C., and Israel, A. (1999) Mol. Cell. Biol. 19, 6345-6354 |
| 57. | Potapova, O., Gorospe, M., Dougherty, R. H., Dean, N. M., Gaarde, W. A., and Holbrook, N. J. (2000) Mol. Cell. Biol. 20, 1713-1722 |
| 58. | Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr. (1997) Mol. Cell. Biol. 17, 3629-3639 |
| 59. | Zwacka, R. M., Stark, L., and Dunlop, M. G. (2000) J. Gene Med. 2, 334-343 |
| 60. | Romashkova, J. A., and Makarov, S. S. (1999) Nature 401, 86-90 |
| 61. | Mazars, A., Tournigand, C., Mollat, P., Prunier, C., Ferrand, N., Bourgeade, M. F., Gespach, C., and Atfi, A. (2000) Oncogene 19, 1277-1287 |
This article has been cited by other articles:
![]() |
S. H. Ki, M. J. Choi, C. H. Lee, and S. G. Kim G{alpha}12 Specifically Regulates COX-2 Induction by Sphingosine 1-Phosphate: ROLE FOR JNK-DEPENDENT UBIQUITINATION AND DEGRADATION OF I{kappa}B{alpha} J. Biol. Chem., January 19, 2007; 282(3): 1938 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hargett, S. Rice, and S. L. Bachenheimer Herpes Simplex Virus Type 1 ICP27-Dependent Activation of NF-{kappa}B J. Virol., November 1, 2006; 80(21): 10565 - 10578. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Cho, A. E. Jedlicka, R. Clarke, and S. R. Kleeberger Role of Toll-like receptor-4 in genetic susceptibility to lung injury induced by residual oil fly ash Physiol Genomics, June 16, 2005; 22(1): 108 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Abraham, K. V. Ballman, A. Dispenzieri, D. E. Grill, M. K. Manske, T. L. Price-Troska, N. G. Paz, M. A. Gertz, and R. Fonseca Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis Blood, January 15, 2005; 105(2): 794 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ougolkov, B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, and T. Minamoto Associations Among {beta}-TrCP, an E3 Ubiquitin Ligase Receptor, {beta}-Catenin, and NF-{kappa}B in Colorectal Cancer J Natl Cancer Inst, August 4, 2004; 96(15): 1161 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and F. Chen Reactive Oxygen Species (ROS), Troublemakers between Nuclear Factor-{kappa}B (NF-{kappa}B) and c-Jun NH2-terminal Kinase (JNK) Cancer Res., March 15, 2004; 64(6): 1902 - 1905. [Abstract] [Full Text] [PDF] |